                         SEQUENCE LISTING

<110>  H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC.
 
<120>  INHIBITORS FOR THE B-CATENIN / T-CELL FACTOR PROTEIN-PROTEIN 
       INTERACTION

<130>  10110-188WO1

<160>  3     

<170>  PatentIn version 3.5

<210>  1
<211>  53
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic construct

<400>  1

His Gly Gly Gly Asp Asp Leu Gly Ala Asn Asp Glu Leu Ile Ser Phe 
1               5                   10                  15      


Lys Asp Glu Gly Glu Gln Glu Glu Lys Ser Ser Glu Asn Ser Ser Ala 
            20                  25                  30          


Glu Arg Asp Leu Ala Asp Val Lys Ser Ser Leu Val Asn Glu Lys Phe 
        35                  40                  45              


Ile Thr Cys Asn His 
    50              


<210>  2
<211>  63
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic construct

<400>  2

His Asp Thr Asp Pro Thr Ala Pro Pro Tyr Asp Ser Leu Leu Val Phe 
1               5                   10                  15      


Asp Tyr Glu Gly Ser Gly Ser Glu Ala Ala Ser Leu Ser Ser Leu Asn 
            20                  25                  30          


Ser Ser Glu Ser Asp Lys Asp Gln Asp Tyr Asp Tyr Leu Asn Glu Trp 
        35                  40                  45              


Gly Asn Arg Phe Lys Lys Leu Ala Lys Phe Ile Thr Cys Asn His 
    50                  55                  60              


<210>  3
<211>  51
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic construct

<400>  3

His Gln Arg Val Gln Val Leu Pro Asp Ala Asp Thr Leu Leu His Phe 
1               5                   10                  15      


Ala Thr Glu Ser Thr Pro Asp Gly Phe Ser Cys Ser Ser Ser Leu Ser 
            20                  25                  30          


Ala Leu Ser Leu Asp Glu Pro Phe Ile Gln Lys Asp Lys Phe Ile Thr 
        35                  40                  45              


Cys Asn His 
    50      


